Conventional wisdom holds that as we get closer and closer to the coming deadline for tariff resolution, the market will become more treacherous, especially for highly valued stocks. I don’t know who writes these stories. I always check the bylines and I have never worked with them or hired them. I will tell you this: their lack of knowledge of how the market works is painful. Their shoddy knowledge of market history would never be tolerated in any classroom. They are, what we used to call at The Harvard Crimson, “filler-up stories,” meaning stories that had to be written because copy was needed. In truth, while the deadline looms, there is no relation between the highly valued stocks and the events at hand. I actually expect severe news about South Korea and Japan before Aug. 1 — the Trump administration’s “hard deadline,” in the words of Commerce Secretary Howard Lutnick, for when new country-specific duty rates will come into effect. Korean car companies “make” vehicles here, but the White House would argue to you that all they do is assemble them here, while the more highly valued pieces of a car are made in the home country. Japan makes even less here but is defended, like Korea, by our soldiers, and I could see President Donald Trump invoking that fact to put on some capricious number — call it 35% tariffs on their imports — because that level is eye-grabbing. So, I doubt we’re even going to get to the drop dead date of Aug. 1 without more drama. Does anyone who trades or invests think that the tariffs will influence the most highly valued stocks, none other than my newly minted cohort called PARC — Palantir , Applovin , Robinhood and Coinbase ? These all have room to run because if you are willing to pay 100 times earnings it means nothing to pay 200. That’s the gospel. How can these writers not know that? Can Palantir be stopped by Canadian tariffs? Oh please, and if crypto gets knocked down, it will get up again. It’s never going to keep that down. Let’s flip this moment on its head and question what’s buoying the near-record market as second-quarter earnings season picks up steam (we have five Club names reporting this week). I have 10 things on the list, some already happening and others more forward-looking. First, and most obvious: earnings have been terrific. Yes, there is an occasional Abbott Labs , which was brutalized by China, or Netflix , which was challenged by sky-high expectations. But the banks have set the tone, and the pastiche that closed out the week all came in very strong. I expect that to continue, with the only potential weak spot being the drugmakers. Just not enough blockbusters and some very weak pipelines. It’s been a brutal year for health care overall, sitting last among all 11 sectors in the S & P 500 . Second, Trump’s “big beautiful bill” contains so many provisions that will boost the economy that I think we need to rethink the possibility of a hobbled consumer. Consider these: An extension of…
Read More: 10 things going the right way for stocks as another tariff deadline looms